NovaRad has recently received U.S. Food and Drug Administration (FDA)clearance for reading and interpreting mammography studies for its NovaPACS which is used for the distribution and viewing of mammography studies, including window,level,zoom and volumetric measurements.
If you enjoy this content, please share it with a colleague
Related Content
March 9, 2026 — Fujifilm Healthcare Americas Corp. is showcasing how its latest AI-powered enterprise imaging solutions ...
March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...
March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...
Radiology is a cornerstone of modern medical diagnostics, but today it stands at an inflection point. Pressures ...
Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...
Feb. 12, 2026 — Agfa HealthCare continued its strong business momentum across the U.S. market, as health systems expand ...
Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...
Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...
Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...
Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...
March 10, 2026 